Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations
Crossref DOI link: https://doi.org/10.1007/s12185-017-2369-z
Published Online: 2017-11-17
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nogami, Keiji
Shima, Midori
Fukutake, Katsuyuki
Fujii, Teruhisa
Taki, Masashi
Matsushita, Tadashi
Higasa, Satoshi
Sato, Tetsuji
Sakai, Michio
Arai, Morio
Uchikawa, Haruhiko
Engl, Werner
Abbuehl, Brigitt
Konkle, Barbara A.
License valid from 2017-11-17